National Center for Complementary & Integrative Health; Notice of Meeting, 3707 [2020-00895]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 14 / Wednesday, January 22, 2020 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: John H. Newman, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222,
MSC 7808, Bethesda, MD 20892, (301) 435–
0628, newmanjh@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 15, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–00899 Filed 1–21–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Center for Complementary &
Integrative Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Complementary and
Integrative Health.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Integrative
Health.
Date: June 5, 2020.
Closed: 8:30 a.m. to 9:45 a.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
16:42 Jan 21, 2020
Jkt 250001
Place: National Institute of General
Medical Science, Natcher Bldg., E1/E2, 45
Center Drive, Bethesda, MD 20892.
Open: 10:00 a.m. to 4:00 p.m.
Agenda: A report from the Director of the
Center and Other Staff.
Place: National Institute of General
Medical Science, Natcher Bldg., E1/E2, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Partap Singh Khalsa,
Ph.D., DC, Director, Division of Extramural
Activities, National Center for
Complementary and Integrative Health,
National Institutes of Health, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892–5475, 301–594–3462, khalsap@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
nccih.nih.gov/about/naccih, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: January 15, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–00895 Filed 1–21–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Notice of Issuance of Final
Determination Concerning Certain
Videoscopes
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of final determination.
AGENCY:
This document provides
notice that U.S. Customs and Border
Protection (‘‘CBP’’) has issued a final
determination concerning the country of
origin of certain videoscopes (or remote
visual inspection equipment). Based
upon the facts presented, CBP has
concluded that the country of origin of
SUMMARY:
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
3707
the videoscopes in question is Japan, for
purposes of U.S. Government
procurement.
DATES: The final determination was
issued on January 14, 2020. A copy of
the final determination is attached. Any
party-at-interest, as defined in 19 CFR
177.22(d), may seek judicial review of
this final determination within February
21, 2020.
FOR FURTHER INFORMATION CONTACT: Joy
Marie Virga, Valuation and Special
Programs Branch, Regulations and
Rulings, Office of Trade, at (202) 325–
1511.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that on January 14, 2020,
pursuant to subpart B of part 177, U.S.
Customs and Border Protection
Regulations (19 CFR part 177, subpart
B), CBP issued a final determination
concerning the country of origin of
certain videoscopes (IPLEX GT and GX
Videoscopes), imported by Olympus
Scientific Solutions Technologies Inc.
(‘‘OSST’’), which may be offered to the
U.S. Government under an
undesignated government procurement
contract. This final determination,
Headquarters Ruling Letter (‘‘HQ’’)
H303139, was issued under procedures
set forth at 19 CFR part 177, subpart B,
which implements Title III of the Trade
Agreements Act of 1979, as amended
(19 U.S.C. 2511–18). In the final
determination, CBP concluded that the
country of origin of the videoscopes is
Japan for purposes of U.S. Government
procurement.
Section 177.29, CBP Regulations (19
CFR 177.29), provides that a notice of
final determination shall be published
in the Federal Register within 60 days
of the date the final determination is
issued. Section 177.30, CBP Regulations
(19 CFR 177.30), provides that any
party-at-interest, as defined in 19
CFR177.22(d), may seek judicial review
of a final determination within 30 days
of publication of such determination in
the Federal Register.
Dated: January 14, 2020.
Alice A. Kipel,
Executive Director, Regulations and Rulings,
Office of Trade.
HQ H303139
January 14, 2020
OT:RR:CTF:VS H303139 YAG/JMV
CATEGORY: Origin
Mr. Daniel Shapiro
Olympus Scientific Solutions Americas
48 Woerd Avenue
Waltham, MA 02453
RE: U.S. Government Procurement;
Country of Origin of Videoscopes;
E:\FR\FM\22JAN1.SGM
22JAN1
]]>Agencies
[Federal Register Volume 85, Number 14 (Wednesday, January 22, 2020)]
[Notices]
[Page 3707]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00895]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Integrative Health; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Complementary and Integrative Health.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Complementary
and Integrative Health.
Date: June 5, 2020.
Closed: 8:30 a.m. to 9:45 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of General Medical Science, Natcher
Bldg., E1/E2, 45 Center Drive, Bethesda, MD 20892.
Open: 10:00 a.m. to 4:00 p.m.
Agenda: A report from the Director of the Center and Other
Staff.
Place: National Institute of General Medical Science, Natcher
Bldg., E1/E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Partap Singh Khalsa, Ph.D., DC, Director,
Division of Extramural Activities, National Center for Complementary
and Integrative Health, National Institutes of Health, 6707
Democracy Blvd., Suite 401, Bethesda, MD 20892-5475, 301-594-3462,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://nccih.nih.gov/about/naccih, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.213,
Research and Training in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: January 15, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-00895 Filed 1-21-20; 8:45 am]
BILLING CODE 4140-01-P
